Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Gram-Negative Bacterial Infections, Date of authorisation: 13/02/2020, Revision: 1, Status: Authorised

SEMrush
Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Gram-Negative Bacterial Infections, Date of authorisation: 13/02/2020, Revision: 1, Status: Authorised
[automaticbacklinks]